Forskning ved Københavns Universitet - Københavns Universitet

Forside

The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Standard

The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat. / Kristensen, Søren; Thomsen, Morten Skøtt; Hansen, Henrik H; Timmermann, Daniel B; Hay-Schmidt, Anders; Mikkelsen, Jens D.

I: Neuroscience Letters, Bind 418, Nr. 2, 17.05.2007, s. 154-8.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

Harvard

Kristensen, S, Thomsen, MS, Hansen, HH, Timmermann, DB, Hay-Schmidt, A & Mikkelsen, JD 2007, 'The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat', Neuroscience Letters, bind 418, nr. 2, s. 154-8. https://doi.org/10.1016/j.neulet.2007.03.016

APA

Kristensen, S., Thomsen, M. S., Hansen, H. H., Timmermann, D. B., Hay-Schmidt, A., & Mikkelsen, J. D. (2007). The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat. Neuroscience Letters, 418(2), 154-8. https://doi.org/10.1016/j.neulet.2007.03.016

Vancouver

Kristensen S, Thomsen MS, Hansen HH, Timmermann DB, Hay-Schmidt A, Mikkelsen JD. The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat. Neuroscience Letters. 2007 maj 17;418(2):154-8. https://doi.org/10.1016/j.neulet.2007.03.016

Author

Kristensen, Søren ; Thomsen, Morten Skøtt ; Hansen, Henrik H ; Timmermann, Daniel B ; Hay-Schmidt, Anders ; Mikkelsen, Jens D. / The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat. I: Neuroscience Letters. 2007 ; Bind 418, Nr. 2. s. 154-8.

Bibtex

@article{3a737d6ca5dc4991943f0b7ceee2e11c,
title = "The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat",
abstract = "Nicotinic alpha7 acetylcholine receptors (alpha7 nAChR) have been shown to enhance attentional function and aspects of memory function in experimental models and in man. The protein Arc encoded by the effector immediate early gene arc or arg3.1 has been shown to be strongly implicated in long-term memory function. We have sought to determine if alpha7 nAChR mediate the stimulation of arc gene expression, and if so, where in the brain such activation may occur using semi-quantitative in situ hybridisation. Administration of the novel and selective alpha7 nAChR agonist, SSR180711 (1, 3 and 10 mg/kg) to adolescent rats, produced a dose- and time-dependent increase in the expression of Arc mRNA in the prefrontal cortex and the ventral orbital cortex. By contrast, no change in mRNA levels was detected in the parietal cortex and the CA1 of the hippocampus. These data show that alpha7 nAChR activates a subset of neurons in the rat prefrontal cortex and this activation likely is important for the attentional effects of this new class of drugs.",
keywords = "Acetylcholine, Animals, Attention, Attention Deficit Disorder with Hyperactivity, Bicyclo Compounds, Heterocyclic, Cytoskeletal Proteins, Dose-Response Relationship, Drug, Gene Expression Regulation, In Situ Hybridization, Male, Memory, Memory Disorders, Nerve Tissue Proteins, Nicotinic Agonists, Prefrontal Cortex, RNA, Messenger, Rats, Rats, Wistar, Receptors, Nicotinic, Synaptic Transmission, Time Factors, Up-Regulation, alpha7 Nicotinic Acetylcholine Receptor",
author = "S{\o}ren Kristensen and Thomsen, {Morten Sk{\o}tt} and Hansen, {Henrik H} and Timmermann, {Daniel B} and Anders Hay-Schmidt and Mikkelsen, {Jens D}",
year = "2007",
month = may,
day = "17",
doi = "10.1016/j.neulet.2007.03.016",
language = "English",
volume = "418",
pages = "154--8",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - The alpha7 nicotinic receptor agonist SSR180711 increases activity regulated cytoskeleton protein (Arc) gene expression in the prefrontal cortex of the rat

AU - Kristensen, Søren

AU - Thomsen, Morten Skøtt

AU - Hansen, Henrik H

AU - Timmermann, Daniel B

AU - Hay-Schmidt, Anders

AU - Mikkelsen, Jens D

PY - 2007/5/17

Y1 - 2007/5/17

N2 - Nicotinic alpha7 acetylcholine receptors (alpha7 nAChR) have been shown to enhance attentional function and aspects of memory function in experimental models and in man. The protein Arc encoded by the effector immediate early gene arc or arg3.1 has been shown to be strongly implicated in long-term memory function. We have sought to determine if alpha7 nAChR mediate the stimulation of arc gene expression, and if so, where in the brain such activation may occur using semi-quantitative in situ hybridisation. Administration of the novel and selective alpha7 nAChR agonist, SSR180711 (1, 3 and 10 mg/kg) to adolescent rats, produced a dose- and time-dependent increase in the expression of Arc mRNA in the prefrontal cortex and the ventral orbital cortex. By contrast, no change in mRNA levels was detected in the parietal cortex and the CA1 of the hippocampus. These data show that alpha7 nAChR activates a subset of neurons in the rat prefrontal cortex and this activation likely is important for the attentional effects of this new class of drugs.

AB - Nicotinic alpha7 acetylcholine receptors (alpha7 nAChR) have been shown to enhance attentional function and aspects of memory function in experimental models and in man. The protein Arc encoded by the effector immediate early gene arc or arg3.1 has been shown to be strongly implicated in long-term memory function. We have sought to determine if alpha7 nAChR mediate the stimulation of arc gene expression, and if so, where in the brain such activation may occur using semi-quantitative in situ hybridisation. Administration of the novel and selective alpha7 nAChR agonist, SSR180711 (1, 3 and 10 mg/kg) to adolescent rats, produced a dose- and time-dependent increase in the expression of Arc mRNA in the prefrontal cortex and the ventral orbital cortex. By contrast, no change in mRNA levels was detected in the parietal cortex and the CA1 of the hippocampus. These data show that alpha7 nAChR activates a subset of neurons in the rat prefrontal cortex and this activation likely is important for the attentional effects of this new class of drugs.

KW - Acetylcholine

KW - Animals

KW - Attention

KW - Attention Deficit Disorder with Hyperactivity

KW - Bicyclo Compounds, Heterocyclic

KW - Cytoskeletal Proteins

KW - Dose-Response Relationship, Drug

KW - Gene Expression Regulation

KW - In Situ Hybridization

KW - Male

KW - Memory

KW - Memory Disorders

KW - Nerve Tissue Proteins

KW - Nicotinic Agonists

KW - Prefrontal Cortex

KW - RNA, Messenger

KW - Rats

KW - Rats, Wistar

KW - Receptors, Nicotinic

KW - Synaptic Transmission

KW - Time Factors

KW - Up-Regulation

KW - alpha7 Nicotinic Acetylcholine Receptor

U2 - 10.1016/j.neulet.2007.03.016

DO - 10.1016/j.neulet.2007.03.016

M3 - Journal article

C2 - 17379406

VL - 418

SP - 154

EP - 158

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -

ID: 111182816